SPYRE THERAPEUTICS, INC. (SYRE)
Spyre Therapeutics Announces Grants of Inducement Awards
HAWAIIAN ELECTRIC INDUSTRIES INC (HE)
HEI Reports Second Quarter 2026 Results
KOPIN CORP (KOPN)
Kopin Corporation to Host Second Quarter 2026 Earnings Call on Monday, August 10, 2026 at 5:00 PM Eastern Time
Im Cannabis Corp (IMCC)
IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
CAREDX, INC. (CDNA)
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATYR PHARMA INC (ATYR)
aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
IM CANNABIS CORP. (IMCC)
IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
INTELLIA THERAPEUTICS, INC. (NTLA)
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (KNSA)
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
INSPIREMD, INC. (NSPR)
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)